Stay updated on Nivolumab Ibrutinib in CLL Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Ibrutinib in CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Ibrutinib in CLL Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The Publications section now displays auto-filled PubMed notes and includes a new revision label (v3.3.2). The older PubMed-source description was removed and replaced with the updated revision tag (v3.2.0).
    Difference
    0.1%
    Check dated 2025-11-25T10:24:56.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page no longer displays a notice about government funding and NIH operations status, which was a meta-information banner rather than core study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T06:47:47.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    No notable changes detected; the page content and layout remain focused on the NCT02420912 study details.
    Difference
    0.4%
    Check dated 2025-11-03T20:41:23.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Page now includes a government funding status notice and new version v3.2.0; a disease term (B-cell chronic lymphocytic leukemia) was removed.
    Difference
    3%
    Check dated 2025-10-06T04:45:07.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Updated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.
    Difference
    0.1%
    Check dated 2025-09-29T02:54:00.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Update: Revision updated to v3.0.2 from v3.0.1. Also, the Back to Top element was removed.
    Difference
    0.2%
    Check dated 2025-09-14T18:50:42.000Z thumbnail image

Stay in the know with updates to Nivolumab Ibrutinib in CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Ibrutinib in CLL Clinical Trial page.